266 related articles for article (PubMed ID: 6105934)
1. Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.
Fabre J; Fox HM; Dayer P; Balant L
Clin Pharmacokinet; 1980; 5(5):441-64. PubMed ID: 6105934
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
3. Altered pharmacokinetics of beta-adrenoceptor blocking drugs in patients with renal insufficiency.
Tjandramaga TB
Arch Int Pharmacodyn Ther; 1980; Suppl():38-53. PubMed ID: 6106457
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
6. Principles of drug therapy in patients with renal disease.
Bennett WM
West J Med; 1975 Nov; 123(5):372-9. PubMed ID: 1210331
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.
Piepho RW; Fendler KJ
Drugs Aging; 1991 May; 1(3):194-211. PubMed ID: 1686570
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.
Drayer DE
Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.
Riddell JG; Harron DW; Shanks RG
Clin Pharmacokinet; 1987 May; 12(5):305-20. PubMed ID: 2886244
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
Hoyer J; Schulte KL; Lenz T
Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
Borchard U
Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
[TBL] [Abstract][Full Text] [Related]
12. Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function.
Kintzel PE; Dorr RT
Cancer Treat Rev; 1995 Jan; 21(1):33-64. PubMed ID: 7859226
[TBL] [Abstract][Full Text] [Related]
13. Renal failure, drug pharmacokinetics and drug action.
Fabre J; Balant L
Clin Pharmacokinet; 1976; 1(2):99-120. PubMed ID: 13956
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of beta-adrenoreceptors blockers.
Johnsson G; Regårdh CG
Drugs; 1976; 11 SUPPL 1():111-21. PubMed ID: 6243
[TBL] [Abstract][Full Text] [Related]
15. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
16. Dosage adjustment of quinolone antibiotics and angiotensin-converting enzyme inhibitors in patients with renal dysfunction.
Ohtani H; Kinoshita Y; Nagasaki Y; Sata H; Miki A; Tsujimoto M; Sawada Y
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):428-37. PubMed ID: 16995331
[TBL] [Abstract][Full Text] [Related]
17. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological rationale for antihypertensive drug treatment.
Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S6-17. PubMed ID: 2454370
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic aspects of some beta-adrenoceptor blocking drugs.
Regårdh CG
Acta Med Scand Suppl; 1982; 665():49-60. PubMed ID: 6130675
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of newer drugs in patients with renal impairment (Part II).
Singlas E; Fillastre JP
Clin Pharmacokinet; 1991 May; 20(5):389-410. PubMed ID: 1879096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
